Endometriosis Management Guidelines

Diagnosis and Initial Evaluation

The American Academy of Family Physicians recommends that diagnosis is based on clinical symptoms, such as secondary dysmenorrhea, deep dyspareunia, and sacral backache with menses 1
Histologic examination should confirm the presence of endometrial lesions, especially those with non-classical appearance 1
Peritoneal biopsy may be used to diagnose questionable peritoneal lesions 1

The American College of Family Physicians suggests that NSAIDs are effective first-line agents for pain management 2
Oral contraceptives provide effective pain relief compared to placebo and may be equivalent to more costly regimens 2
Progestins (oral or depot medroxyprogesterone acetate) are effective alternatives with similar efficacy to other hormonal treatments 2
GnRH agonists for at least three months provide significant pain relief 2, 3
When using GnRH agonists, add-back therapy should be implemented to reduce or eliminate bone mineral loss without reducing pain relief efficacy 2, 3

Surgery provides significant pain reduction during the first six months following the procedure 1
For severe endometriosis, medical treatment alone may not be sufficient 2
Up to 44% of women experience symptom recurrence within one year after surgery 1
Hormone replacement therapy with estrogen is not contraindicated following hysterectomy and bilateral salpingo-oophorectomy for endometriosis 2

The U.S. Medical Eligibility Criteria for Contraceptive Use classifies endometriosis as Category 1 (no restrictions) for combined hormonal contraceptive use, meaning women with endometriosis can safely use these medications without concern for worsening their condition 4
A Cochrane Collaboration Review found that women with endometriosis using combined oral contraceptives did not report worsening of their condition or adverse events related to COC use 4